Coronavirus disease 2019 (COVID-19)

The virus is called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)


  1. Arentz. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA 2020;epublished March 19th
  2. Cao. Clinical features and short‑term outcomes of 18 patients with corona virus disease 2019 in intensive care unit. Intensive Care Med 2020;epublished March 2nd
  3. Guan. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020;epublished February 28th
  4. Lan. Positive RT-PCR Test Results in Patients Recovered From COVID-19. JAMA 2020;epublished February 27th
  5. Pan. Challenges and countermeasures for organ donation during the SARS-CoV-2 epidemic: the experience of Sichuan Provincial People’s Hospital. Intensive Care Med 2020;epublished February 25th
  6. Wu. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China. Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 2020;epublished February 24th
  7. Wei. Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China. JAMA 2020;epublished February 14th
  8. Bai. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA 2020;epublished February 21st
  9. Huang. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497-506
  10. Chen. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395(10223)P507-513
  11. Chan. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020;395(10223):514-523
  12. Zhu. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020;382:727-733


  1. Bachireddy. Securing the Safety Net and Protecting Public Health During a Pandemic. Medicaid’s Response to COVID-19. JAMA 2020;epublished March 19th
  2. Parmet. Covid-19 - The Law and Limits of Quarantine. N Engl J Med 2020;epublished March 18th
  3. Rosenbaum. Facing Covid-19 in Italy — Ethics, Logistics, and Therapeutics on the Epidemic’s Front Line. N Engl J Med 2020;epublished March 18th
  4. Xiao. Taking the right measures to control COVID-19. Lancet Infect Dis 2020;epublished March 5th
  5. Arabi. COVID-19: a novel coronavirus and a novel challenge for critical care. Intensive Care Med 2020;epublished March 3rd
  6. Zhang. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med 2020;epublished March 3rd
  7. Wang. Response to COVID-19 in Taiwan. Big Data Analytics, New Technology, and Proactive Testing. JAMA 2020;epublished March 3rd
  8. Adalja. Priorities for the US Health Community Responding to COVID-19. JAMA 2020;epublished March 3rd
  9. Lippi. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med 2020;epublished March 3rd
  10. Peckham. COVID-19 and the anti-lessons of history. Lancet 2020;epublished March 2nd
  11. Xie. Critical care crisis and some recommendations during the COVID-19 epidemic in China. Intensive Care Med 2020;epublished March 2nd
  12. Olson. Diagnosis and Treatment of Adults With Community-Acquired Pneumonia. JAMA 2020;323(9):885-886
  13. Zhang. Clinical trials for the treatment of Coronavirus disease 2019 (COVID-19): A rapid response to urgent need. Sci China Life Sci 2020;epublished February 29th
  14. Chen. From SARS-CoV to 2019-nCoV Outbreak: Similarities in the Early Epidemics and Prediction of Future Trends. Chin Med J 2020;epublished February 28th
  15. del Rio. COVID-19—New Insights on a Rapidly Changing Epidemic. JAMA 2020;epublished February 28th
  16. Gates. Responding to Covid-19 — A Once-in-a-Century Pandemic? N Engl J Med 2020;epublished February 28th
  17. Chen. Convalescent plasma as a potential therapy for COVID-19. Lancet Infect Dis 2020;epublished February 27th
  18. Nkengasong. Looming threat of COVID-19 infection in Africa: act collectively, and fast. Lancet 2020;epublished February 27th
  19. Stebbing. COVID-19: combining antiviral and anti-inflammatory treatments. Lancet Infect Dis 2020;epublished February 27th
  20. Morens. Escaping Pandora’s Box — Another Novel Coronavirus. N Engl J Med 2020;epublished February 26th
  21. Bouadma. Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists. Intensive Care Med 2020;epublished February 26th
  22. Jiang. The First Disease X is Caused by a Highly Transmissible Acute Respiratory Syndrome Coronavirus. Virologica Sinica 2020;epublished February 14th
  23. Guo. Old Weapon for New Enemy: Drug Repurposing for Treatment of Newly Emerging Viral Diseases. Virologica Sinica 2020;epublished February 11th
  24. Wu. Compensation of ACE2 Function for Possible Clinical Management of 2019-nCoV-Induced Acute Lung Injury. Virologica Sinica 2020;epublished February 7th
  25. Qiao. What are the risks of COVID-19 infection in pregnant women? Lancet 2020;395(10226):760-762
  26. Ghebreyesus. Scientists are sprinting to outpace the novel coronavirus. Lancet 2020;395(10226):762-764
  27. Chen. COVID-19 control in China during mass population movements at New Year. Lancet 2020;395(10226):764-766
  28. Wong. COVID-19 in Singapore—Current Experience. Critical Global Issues That Require Attention and Action. JAMA 2020;epublished February 20th
  29. MacLaren. Preparing for the Most Critically Ill Patients With COVID-19. The Potential Role of Extracorporeal Membrane Oxygenation. JAMA 2020;epublished February 19th
  30. Swerdlow. Preparation for Possible Sustained Transmission of 2019 Novel Coronavirus. Lessons From Previous Epidemics. JAMA 2020;epublished February 11th
  31. del Rio. 2019 Novel Coronavirus—Important Information for Clinicians. JAMA 2020;epublished February 5th
  32. Battegay.  2019-Novel coronavirus (2019-nCoV): estimating the case fatality rate: a word of caution. Swiss Med Wkly 2020;150:w20203
  33. McCloskey. SARS to novel coronavirus: old lessons and new lessons. Epidemiol Infect 2020;148:e22
  34. Russell. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 2020;395(10223):473-475
  35. Phelan. The Novel Coronavirus Originating in Wuhan, China. Challenges for Global Health Governance. JAMA 2020;323(8):709-710
  36. Paules. Coronavirus Infections—More Than Just the Common Cold. JAMA 2020;323(8):707-708

Tags: COVID-19, Coronavirus, Pandemic, SARS-CoV-2